🎉 The ATHENA trial has recruited 878 participants, exceeding our original target! We're delighted. A huge well done to everyone involved in helping us investigate whether taking amitriptyline can stop long-term pain from shingles. #GPSky #Primarycare @riddmj.bsky.social @capcbristol.bsky.social

WE HAVE REACHED THE END OF RECRUITMENT!! 🎯 Our last randomisations have been completed today 👏 Thank you to everyone involved for your amazing hard work and contributions! #GPSky #Primarycare @riddmj.bsky.social @capcbristol.bsky.social

The ATHENA Study only needs 39 more patients to hit the target of 900. Read more at www.bristol.ac.uk/athena-study @capcbristol.bsky.social @nihrspcr.bsky.social

Our research team are on a roll and we are thrilled we now have 846 participants! An amazing achievement! 🙌🥳 Thank you to everyone involved for their hard work...keep going!! 🏃 #GPSky #Primarycare @riddmj.bsky.social @capcbristol.bsky.social

Congratulations to the @athenastudy.bsky.social team, who have successfully reached their recruitment target of 846 patients 2 months ahead of schedule! 🎉 ATHENA is looking at whether taking amitriptyline tablets can stop long-term pain from shingles. Find out more: athena-study.bristol.ac.uk

Recruitment update: we have 830 participants so far! 🚀🎯🚀 @capcbristol.bsky.social @riddmj.bsky.social #shingles #PrimaryCare #GPSky

Hi! We're on Bluesky! We're a A NIHR Research funded study, to find out if amitriptyline can prevent pain after shingles (post-herpetic neuralgia). #PrimaryCare #GPSky @capcbristol.bsky.social @riddmj.bsky.social

We are pleased to announce that our protocol paper is out ⬇️ Amitriptyline for the prevention of post-herpetic neuralgia: study protocol for the ATHENA study. Skin Health and Disease, 2025; DOI: doi.org/10.1093/skin... #PrimaryCare #GPSky @capcbristol.bsky.social @riddmj.bsky.social